{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T18:30:52Z","timestamp":1764873052128},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,5,16]],"date-time":"2009-05-16T00:00:00Z","timestamp":1242432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,5,16]],"date-time":"2009-05-16T00:00:00Z","timestamp":1242432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1007\/s12016-009-8131-4","type":"journal-article","created":{"date-parts":[[2009,5,15]],"date-time":"2009-05-15T03:35:04Z","timestamp":1242358504000},"page":"39-53","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Use of Cytokine Therapy in Primary Immunodeficiency"],"prefix":"10.1007","volume":"38","author":[{"given":"Sumita","family":"Roy-Ghanta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan S.","family":"Orange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,5,16]]},"reference":[{"issue":"3\u20135","key":"8131_CR1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0171-2985(86)80097-3","volume":"172","author":"KM Zsebo","year":"1986","unstructured":"Zsebo KM, Cohen AM et al (1986) Recombinant human granulocyte colony stimulating factor: molecular and biological characterization. Immunobiology 172(3\u20135):175\u2013184","journal-title":"Immunobiology"},{"key":"8131_CR2","first-page":"40","volume":"204","author":"D Metcalf","year":"1997","unstructured":"Metcalf D (1997) The molecular control of granulocytes and macrophages. Ciba Found Symp 204:40\u201350; discussion 50\u201346","journal-title":"Ciba Found Symp"},{"issue":"2","key":"8131_CR3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1189\/jlb.0603252","volume":"75","author":"K Schroder","year":"2004","unstructured":"Schroder K, Hertzog PJ et al (2004) Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75(2):163\u2013189","journal-title":"J Leukoc Biol"},{"key":"8131_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ijpharm.2008.11.027","volume":"369","author":"S Thitinan","year":"2009","unstructured":"Thitinan S, McConville JT (2009) Interferon alpha delivery systems for the treatment of hepatitis C. Int J Pharm 369:121\u2013135","journal-title":"Int J Pharm"},{"issue":"4","key":"8131_CR5","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.4049\/jimmunol.131.4.1808","volume":"131","author":"KA Smith","year":"1983","unstructured":"Smith KA, Favata MF et al (1983) Production and characterization of monoclonal antibodies to human interleukin 2: strategy and tactics. J Immunol 131(4):1808\u20131815","journal-title":"J Immunol"},{"issue":"20","key":"8131_CR6","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1056\/NEJM197011122832002","volume":"283","author":"K Wriedt","year":"1970","unstructured":"Wriedt K, Kauder E et al (1970) Defective myelopoiesis in congenital neutropenia. N Engl J Med 283(20):1072\u20131077","journal-title":"N Engl J Med"},{"issue":"4","key":"8131_CR7","first-page":"282","volume":"117","author":"B Weston","year":"1991","unstructured":"Weston B, Todd RF 3rd et al (1991) Severe congenital neutropenia: clinical effects and neutrophil function during treatment with granulocyte colony-stimulating factor. J Lab Clin Med 117(4):282\u2013290","journal-title":"J Lab Clin Med"},{"issue":"5","key":"8131_CR8","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1182\/blood.V75.5.1056.1056","volume":"75","author":"K Welte","year":"1990","unstructured":"Welte K, Zeidler C et al (1990) Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia. Blood 75(5):1056\u20131063","journal-title":"Blood"},{"issue":"1 Pt 2","key":"8131_CR9","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1016\/0090-1229(92)90039-Q","volume":"62","author":"LA Boxer","year":"1992","unstructured":"Boxer LA, Hutchinson R et al (1992) Recombinant human granulocyte-colony-stimulating factor in the treatment of patients with neutropenia. Clin Immunol Immunopathol 62(1 Pt 2):S39\u2013S46","journal-title":"Clin Immunol Immunopathol"},{"issue":"10","key":"8131_CR10","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1182\/blood.V81.10.2496.2496","volume":"81","author":"DC Dale","year":"1993","unstructured":"Dale DC, Bonilla MA et al (1993) A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood 81(10):2496\u20132502","journal-title":"Blood"},{"issue":"Suppl 105","key":"8131_CR11","first-page":"1","volume":"45","author":"R Kostmann","year":"1956","unstructured":"Kostmann R (1956) Infantile genetic agranulocytosis; agranulocytosis infantilis hereditaria. Acta Paediatr Suppl 45(Suppl 105):1\u201378","journal-title":"Acta Paediatr Suppl"},{"issue":"10","key":"8131_CR12","doi-asserted-by":"publisher","first-page":"4954","DOI":"10.1182\/blood-2007-11-120667","volume":"111","author":"M Germeshausen","year":"2008","unstructured":"Germeshausen M, Grudzien M et al (2008) Novel HAX1 mutations in patients with severe congenital neutropenia reveal isoform-dependent genotype\u2013phenotype associations. Blood 111(10):4954\u20134957","journal-title":"Blood"},{"issue":"24","key":"8131_CR13","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1056\/NEJM198906153202402","volume":"320","author":"MA Bonilla","year":"1989","unstructured":"Bonilla MA, Gillio AP et al (1989) Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med 320(24):1574\u20131580","journal-title":"N Engl J Med"},{"issue":"6","key":"8131_CR14","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1001\/archpedi.1957.04030070035006","volume":"94","author":"AR Page","year":"1957","unstructured":"Page AR, Good RA (1957) Studies on cyclic neutropenia; a clinical and experimental investigation. AMA J Dis Child 94(6):623\u2013661","journal-title":"AMA J Dis Child"},{"issue":"12","key":"8131_CR15","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1172\/JCI107522","volume":"52","author":"Guerry Dt","year":"1973","unstructured":"Guerry DT, Dale DC et al (1973) Periodic hematopoiesis in human cyclic neutropenia. J Clin Invest 52(12):3220\u20133230","journal-title":"J Clin Invest"},{"issue":"1","key":"8131_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00005792-198101000-00001","volume":"60","author":"DG Wright","year":"1981","unstructured":"Wright DG, Dale DC et al (1981) Human cyclic neutropenia: clinical review and long-term follow-up of patients. Medicine (Baltimore) 60(1):1\u201313","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"8131_CR17","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/0268-960X(88)90023-9","volume":"2","author":"DC Dale","year":"1988","unstructured":"Dale DC, WPt H (1988) Cyclic neutropenia: a clinical review. Blood Rev 2(3):178\u2013185","journal-title":"Blood Rev"},{"issue":"20","key":"8131_CR18","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1056\/NEJM198905183202003","volume":"320","author":"H Hammond","year":"1989","unstructured":"Hammond H, Price TH et al (1989) Treatment of cyclic neutropenia with granulocyte colony-stimulating factor. N Engl J Med 320(20):1306\u20131311","journal-title":"N Engl J Med"},{"issue":"1","key":"8131_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1365-2141.1990.tb02631.x","volume":"75","author":"T Hanada","year":"1990","unstructured":"Hanada T, Ono I et al (1990) Childhood cyclic neutropenia treated with recombinant human granulocyte colony stimulating factor. Br J Haematol 75(1):135\u2013137","journal-title":"Br J Haematol"},{"issue":"5","key":"8131_CR20","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1097\/00043426-199709000-00007","volume":"19","author":"JD Hord","year":"1997","unstructured":"Hord JD, Whitlock JA et al (1997) Clinical features of myelokathexis and treatment with hematopoietic cytokines: a case report of two patients and review of the literature. J Pediatr Hematol Oncol 19(5):443\u2013448","journal-title":"J Pediatr Hematol Oncol"},{"issue":"5","key":"8131_CR21","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/0002-9343(90)90187-I","volume":"89","author":"M Wetzler","year":"1990","unstructured":"Wetzler M, Talpaz M et al (1990) A new familial immunodeficiency disorder characterized by severe neutropenia, a defective marrow release mechanism, and hypogammaglobulinemia. Am J Med 89(5):663\u2013672","journal-title":"Am J Med"},{"issue":"16","key":"8131_CR22","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1001\/jama.267.16.2179","volume":"267","author":"M Wetzler","year":"1992","unstructured":"Wetzler M, Talpaz M et al (1992) Myelokathexis: normalization of neutrophil counts and morphology by GM-CSF. JAMA 267(16):2179\u20132180","journal-title":"JAMA"},{"key":"8131_CR23","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.0105-2896.2005.00226.x","volume":"203","author":"GA Diaz","year":"2005","unstructured":"Diaz GA (2005) CXCR4 mutations in WHIM syndrome: a misguided immune system? Immunol Rev 203:235\u2013243","journal-title":"Immunol Rev"},{"issue":"5 Suppl","key":"8131_CR24","doi-asserted-by":"publisher","first-page":"R81","DOI":"10.1007\/s004240000014","volume":"440","author":"P Cernelc","year":"2000","unstructured":"Cernelc P, Andoljsek D et al (2000) Effects of molgramostim, filgrastim and lenograstim in the treatment of myelokathexis. Pflugers Arch 440(5 Suppl):R81\u2013R82","journal-title":"Pflugers Arch"},{"issue":"4","key":"8131_CR25","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1203\/01.PDR.0000139318.65842.4A","volume":"56","author":"A Etzioni","year":"2004","unstructured":"Etzioni A, Ochs HD (2004) The hyper IgM syndrome\u2014an evolving story. Pediatr Res 56(4):519\u2013525","journal-title":"Pediatr Res"},{"issue":"6","key":"8131_CR26","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/01.md.0000100046.06009.b0","volume":"82","author":"JA Winkelstein","year":"2003","unstructured":"Winkelstein JA, Marino MC et al (2003) The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore) 82(6):373\u2013384","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"8131_CR27","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1365-2249.1997.284-ce1174.x","volume":"107","author":"B Ostenstad","year":"1997","unstructured":"Ostenstad B, Giliani S et al (1997) A boy with X-linked hyper-IgM syndrome and natural killer cell deficiency. Clin Exp Immunol 107(2):230\u2013234","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"8131_CR28","first-page":"160","volume":"16","author":"WC Wang","year":"1994","unstructured":"Wang WC, Cordoba J et al (1994) Successful treatment of neutropenia in the hyper-immunoglobulin M syndrome with granulocyte colony-stimulating factor. Am J Pediatr Hematol Oncol 16(2):160\u2013163","journal-title":"Am J Pediatr Hematol Oncol"},{"issue":"40","key":"8131_CR29","first-page":"2169","volume":"136","author":"G Simon","year":"1995","unstructured":"Simon G, Marodi L (1995) Successful treatment of cyclic neutropenia associated with hyperimmunoglobulin M syndrome using recombinant granulocyte-colony stimulating factor. Orv Hetil 136(40):2169\u20132172","journal-title":"Orv Hetil"},{"issue":"8","key":"8131_CR30","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1097\/MPH.0b013e3181758947","volume":"30","author":"ZD Jacobs","year":"2008","unstructured":"Jacobs ZD, Guajardo JR et al (2008) XLA-associated neutropenia treatment: a case report and review of the literature. J Pediatr Hematol Oncol 30(8):631\u2013634","journal-title":"J Pediatr Hematol Oncol"},{"issue":"6108","key":"8131_CR31","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/326088a0","volume":"326","author":"AW Segal","year":"1987","unstructured":"Segal AW (1987) Absence of both cytochrome b-245 subunits from neutrophils in X-linked chronic granulomatous disease. Nature 326(6108):88\u201391","journal-title":"Nature"},{"issue":"8","key":"8131_CR32","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/BF02072210","volume":"150","author":"TJ Muhlebach","year":"1991","unstructured":"Muhlebach TJ, Feickert HJ et al (1991) Granulocyte-macrophage colony stimulating factor does not improve neutrophil oxidative metabolism in a patient with variant X-linked chronic granulomatous disease. Eur J Pediatr 150(8):575\u2013578","journal-title":"Eur J Pediatr"},{"key":"8131_CR33","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.0105-2896.2005.00230.x","volume":"203","author":"KE Nichols","year":"2005","unstructured":"Nichols KE, Ma CS et al (2005) Molecular and cellular pathogenesis of X-linked lymphoproliferative disease. Immunol Rev 203:180\u2013199","journal-title":"Immunol Rev"},{"issue":"5","key":"8131_CR34","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s00431-005-0062-3","volume":"165","author":"N Strnad-Trojan","year":"2006","unstructured":"Strnad-Trojan N, Linde R et al (2006) Treatment of HCV infection with interferon alpha-2b and ribavirin in a patient with X-linked lymphoproliferative syndrome. Eur J Pediatr 165(5):348\u2013350","journal-title":"Eur J Pediatr"},{"issue":"2","key":"8131_CR35","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/01.tp.0000226223.95971.e7","volume":"82","author":"JR Foruny","year":"2006","unstructured":"Foruny JR, Barcena R et al (2006) Benefit of pegylated interferon-alpha-2a\/ribavirin in a patient with common variable immunodeficiency and hepatitis C virus cirrhosis after liver transplantation and splenic embolization. Transplantation 82(2):289\u2013290","journal-title":"Transplantation"},{"issue":"3","key":"8131_CR36","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1159\/000141649","volume":"217","author":"M Bohm","year":"2008","unstructured":"Bohm M, Luger TA et al (2008) Disseminated giant molluscum contagiosum in a patient with idiopathic CD4+ lymphocytopenia. Successful eradication with systemic interferon. Dermatology 217(3):196\u2013198","journal-title":"Dermatology"},{"issue":"2","key":"8131_CR37","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.iac.2008.01.005","volume":"28","author":"AF Freeman","year":"2008","unstructured":"Freeman AF, Holland SM (2008) The hyper-IgE syndromes. Immunol Allergy Clin North Am 28(2):277\u2013291, viii","journal-title":"Immunol Allergy Clin North Am"},{"issue":"6","key":"8131_CR38","doi-asserted-by":"publisher","first-page":"e1253","DOI":"10.1542\/peds.2005-2706","volume":"117","author":"SS Kilic","year":"2006","unstructured":"Kilic SS, Kilicbay F (2006) Interferon-alpha treatment of molluscum contagiosum in a patient with hyperimmunoglobulin E syndrome. Pediatrics 117(6):e1253\u2013e1255","journal-title":"Pediatrics"},{"issue":"5","key":"8131_CR39","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1080\/00015550510030041","volume":"85","author":"G Ozarmagan","year":"2005","unstructured":"Ozarmagan G, Didem Yazganoglu K et al (2005) Hyper-IgE syndrome with widespread premalign oral papillomas treated with interferon alpha2b. Acta Derm Venereol 85(5):433\u2013435","journal-title":"Acta Derm Venereol"},{"issue":"8651","key":"8131_CR40","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/S0140-6736(89)92823-7","volume":"1","author":"G Souillet","year":"1989","unstructured":"Souillet G, Rousset F et al (1989) Alpha-interferon treatment of patient with hyper IgE syndrome. Lancet 1(8651):1384","journal-title":"Lancet"},{"issue":"6","key":"8131_CR41","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/j.1399-3038.2007.00683.x","volume":"19","author":"U Benninghoff","year":"2008","unstructured":"Benninghoff U, Cattaneo F et al (2008) Clinical improvement and normalized Th1 cytokine profile in early and long-term interferon-alpha treatment in a suspected case of hyper-IgE syndrome. Pediatr Allergy Immunol 19(6):564\u2013568","journal-title":"Pediatr Allergy Immunol"},{"issue":"7","key":"8131_CR42","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1097\/ICO.0b013e31806c77d6","volume":"26","author":"G Fuentes-Paez","year":"2007","unstructured":"Fuentes-Paez G, Saornil MA et al (2007) CHARGE association, hyper-immunoglobulin M syndrome, and conjunctival MALT lymphoma. Cornea 26(7):864\u2013867","journal-title":"Cornea"},{"issue":"5","key":"8131_CR43","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.pediatrneurol.2004.05.007","volume":"31","author":"N Shiroma","year":"2004","unstructured":"Shiroma N, Omi T et al (2004) A case of X-linked agammaglobulinemia with progressive encephalitis. Pediatr Neurol 31(5):371\u2013373","journal-title":"Pediatr Neurol"},{"issue":"24","key":"8131_CR44","doi-asserted-by":"publisher","first-page":"10085","DOI":"10.1073\/pnas.86.24.10085","volume":"86","author":"CL King","year":"1989","unstructured":"King CL, Gallin JI et al (1989) Regulation of immunoglobulin production in hyperimmunoglobulin E recurrent-infection syndrome by interferon gamma. Proc Natl Acad Sci U S A 86(24):10085\u201310089","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"8131_CR45","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1089\/jir.1998.18.561","volume":"18","author":"Y Aihara","year":"1998","unstructured":"Aihara Y, Mori M et al (1998) Recombinant IFN-gamma treatment of a patient with hyperimmunoglobulin E syndrome triggered autoimmune thrombocytopenia. J Interferon Cytokine Res 18(8):561\u2013563","journal-title":"J Interferon Cytokine Res"},{"issue":"1","key":"8131_CR46","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1328-0867.2004.01845.x","volume":"46","author":"A Metin","year":"2004","unstructured":"Metin A, Uysal G et al (2004) Tuberculous brain abscess in a patient with hyper IgE syndrome. Pediatr Int 46(1):97\u2013100","journal-title":"Pediatr Int"},{"issue":"3","key":"8131_CR47","first-page":"234","volume":"71","author":"YH Pung","year":"1993","unstructured":"Pung YH, Vetro SW et al (1993) Use of interferons in atopic (IgE-mediated) diseases. Ann Allergy 71(3):234\u2013238","journal-title":"Ann Allergy"},{"issue":"3","key":"8131_CR48","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1006\/bcmd.1995.0028","volume":"21","author":"LS Bemiller","year":"1995","unstructured":"Bemiller LS, Roberts DH et al (1995) Safety and effectiveness of long-term interferon gamma therapy in patients with chronic granulomatous disease. Blood Cells Mol Dis 21(3):239\u2013247","journal-title":"Blood Cells Mol Dis"},{"issue":"4","key":"8131_CR49","first-page":"295","volume":"154","author":"RS Weening","year":"1995","unstructured":"Weening RS, Leitz GJ et al (1995) Recombinant human interferon-gamma in patients with chronic granulomatous disease\u2013European follow up study. Eur J Pediatr 154(4):295\u2013298","journal-title":"Eur J Pediatr"},{"issue":"8","key":"8131_CR50","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJM199102213240801","volume":"324","author":"The International Chronic Granulomatous Disease Cooperative Study Group","year":"1991","unstructured":"The International Chronic Granulomatous Disease Cooperative Study Group (1991) A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med 324(8):509\u2013516","journal-title":"N Engl J Med"},{"issue":"5","key":"8131_CR51","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1086\/422993","volume":"39","author":"BE Marciano","year":"2004","unstructured":"Marciano BE, Wesley R et al (2004) Long-term interferon-gamma therapy for patients with chronic granulomatous disease. Clin Infect Dis 39(5):692\u2013699","journal-title":"Clin Infect Dis"},{"issue":"6","key":"8131_CR52","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1182\/blood.V79.6.1558.1558","volume":"79","author":"RC Woodman","year":"1992","unstructured":"Woodman RC, Erickson RW et al (1992) Prolonged recombinant interferon-gamma therapy in chronic granulomatous disease: evidence against enhanced neutrophil oxidase activity. Blood 79(6):1558\u20131562","journal-title":"Blood"},{"issue":"2","key":"8131_CR53","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-2249.1992.tb03062.x","volume":"88","author":"TJ Muhlebach","year":"1992","unstructured":"Muhlebach TJ, Gabay J et al (1992) Treatment of patients with chronic granulomatous disease with recombinant human interferon-gamma does not improve neutrophil oxidative metabolism, cytochrome b558 content or levels of four anti-microbial proteins. Clin Exp Immunol 88(2):203\u2013206","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"8131_CR54","first-page":"157","volume":"46","author":"A Kantar","year":"1994","unstructured":"Kantar A, Oggiano N et al (1994) Successful interferon gamma therapy in a patient with X-linked chronic granulomatous disease. McLeod syndrome and hyper-IgE. Case report. Minerva Pediatr 46(4):157\u2013160","journal-title":"Minerva Pediatr"},{"issue":"3","key":"8131_CR55","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1056\/NEJM198807213190305","volume":"319","author":"RA Ezekowitz","year":"1988","unstructured":"Ezekowitz RA, Dinauer MC et al (1988) Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma. N Engl J Med 319(3):146\u2013151","journal-title":"N Engl J Med"},{"issue":"11","key":"8131_CR56","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1182\/blood.V95.11.3548","volume":"95","author":"A Condino-Neto","year":"2000","unstructured":"Condino-Neto A, Newburger PE (2000) Interferon-gamma improves splicing efficiency of CYBB gene transcripts in an interferon-responsive variant of chronic granulomatous disease due to a splice site consensus region mutation. Blood 95(11):3548\u20133554","journal-title":"Blood"},{"issue":"8\u20139","key":"8131_CR57","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.annder.2008.02.023","volume":"135","author":"I Marchand","year":"2008","unstructured":"Marchand I, Mahe E et al (2008) Disseminated BCG infection revealing X-linked severe combined immunodeficiency. Ann Dermatol Venereol 135(8\u20139):587\u2013590","journal-title":"Ann Dermatol Venereol"},{"key":"8131_CR58","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJM196508192730806","volume":"273","author":"GS Omenn","year":"1965","unstructured":"Omenn GS (1965) Familial reticuloendotheliosis with eosinophilia. N Engl J Med 273:427\u2013432","journal-title":"N Engl J Med"},{"issue":"1","key":"8131_CR59","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/eji.1830230110","volume":"23","author":"L Schandene","year":"1993","unstructured":"Schandene L, Ferster A et al (1993) T helper type 2-like cells and therapeutic effects of interferon-gamma in combined immunodeficiency with hypereosinophilia (Omenn's syndrome). Eur J Immunol 23(1):56\u201360","journal-title":"Eur J Immunol"},{"issue":"9","key":"8131_CR60","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1086\/425121","volume":"39","author":"MG Netea","year":"2004","unstructured":"Netea MG, Brouwer AE et al (2004) Two patients with cryptococcal meningitis and idiopathic CD4 lymphopenia: defective cytokine production and reversal by recombinant interferon-gamma therapy. Clin Infect Dis 39(9):e83\u2013e87","journal-title":"Clin Infect Dis"},{"issue":"1","key":"8131_CR61","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1053\/srin.2001.22728","volume":"16","author":"SM Holland","year":"2001","unstructured":"Holland SM (2001) Immunotherapy of mycobacterial infections. Semin Respir Infect 16(1):47\u201359","journal-title":"Semin Respir Infect"},{"issue":"12","key":"8131_CR62","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1172\/JCI4950","volume":"102","author":"F Altare","year":"1998","unstructured":"Altare F, Lammas D et al (1998) Inherited interleukin 12 deficiency in a child with bacille Calmette-Guerin and Salmonella enteritidis disseminated infection. J Clin Invest 102(12):2035\u20132040","journal-title":"J Clin Invest"},{"issue":"5368","key":"8131_CR63","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1126\/science.280.5368.1435","volume":"280","author":"R de Jong","year":"1998","unstructured":"de Jong R, Altare F et al (1998) Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 280(5368):1435\u20131438","journal-title":"Science"},{"issue":"3","key":"8131_CR64","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1159\/000088682","volume":"73","author":"P Remiszewski","year":"2006","unstructured":"Remiszewski P, Roszkowska-Sliz B et al (2006) Disseminated Mycobacterium avium infection in a 20-year-old female with partial recessive IFNgammaR1 deficiency. Respiration 73(3):375\u2013378","journal-title":"Respiration"},{"issue":"24","key":"8131_CR65","doi-asserted-by":"publisher","first-page":"10033","DOI":"10.1073\/pnas.87.24.10033","volume":"87","author":"T Chatila","year":"1990","unstructured":"Chatila T, Castigli E et al (1990) Primary combined immunodeficiency resulting from defective transcription of multiple T-cell lymphokine genes. Proc Natl Acad Sci U S A 87(24):10033\u201310037","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"8131_CR66","doi-asserted-by":"publisher","first-page":"4728","DOI":"10.1073\/pnas.90.10.4728","volume":"90","author":"E Castigli","year":"1993","unstructured":"Castigli E, Pahwa R et al (1993) Molecular basis of a multiple lymphokine deficiency in a patient with severe combined immunodeficiency. Proc Natl Acad Sci U S A 90(10):4728\u20134732","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"8131_CR67","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1073\/pnas.86.13.5069","volume":"86","author":"R Pahwa","year":"1989","unstructured":"Pahwa R, Chatila T et al (1989) Recombinant interleukin 2 therapy in severe combined immunodeficiency disease. Proc Natl Acad Sci U S A 86(13):5069\u20135073","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"8131_CR68","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1542\/peds.13.2.133","volume":"13","author":"RA Aldrich","year":"1954","unstructured":"Aldrich RA, Steinberg AG et al (1954) Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea. Pediatrics 13(2):133\u2013139","journal-title":"Pediatrics"},{"issue":"13","key":"8131_CR69","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.1182\/blood-2003-05-1592","volume":"104","author":"Y Jin","year":"2004","unstructured":"Jin Y, Mazza C et al (2004) Mutations of the Wiskott\u2013Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype\/genotype correlation. Blood 104(13):4010\u20134019","journal-title":"Blood"},{"issue":"8","key":"8131_CR70","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/PL00008395","volume":"159","author":"H Azuma","year":"2000","unstructured":"Azuma H, Oshima M et al (2000) Impaired interleukin-2 production in T-cells from a patient with Wiskott\u2013Aldrich syndrome: basis of clinical effect of interleukin-2 replacement therapy. Eur J Pediatr 159(8):633\u2013634","journal-title":"Eur J Pediatr"},{"issue":"12","key":"8131_CR71","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1007\/BF01957224","volume":"152","author":"H Azuma","year":"1993","unstructured":"Azuma H, Sakata H et al (1993) Effect of interleukin 2 on intractable herpes virus infection and chronic eczematoid dermatitis in a patient with Wiskott\u2013Aldrich syndrome. Eur J Pediatr 152(12):998\u20131000","journal-title":"Eur J Pediatr"},{"issue":"6","key":"8131_CR72","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.jaci.2008.08.018","volume":"122","author":"EP Hanson","year":"2008","unstructured":"Hanson EP, Monaco-Shawver L et al (2008) Hypomorphic nuclear factor-kappaB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity. J Allergy Clin Immunol 122(6):1169\u20131177, e1116","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"8131_CR73","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1172\/JCI0214858","volume":"109","author":"JS Orange","year":"2002","unstructured":"Orange JS, Brodeur SR et al (2002) Deficient natural killer cell cytotoxicity in patients with IKK-gamma\/NEMO mutations. J Clin Invest 109(11):1501\u20131509","journal-title":"J Clin Invest"},{"issue":"1","key":"8131_CR74","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1006\/clim.1999.4725","volume":"92","author":"C Cunningham-Rundles","year":"1999","unstructured":"Cunningham-Rundles C, Bodian C (1999) Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 92(1):34\u201348","journal-title":"Clin Immunol"},{"issue":"2","key":"8131_CR75","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1006\/clim.2001.5052","volume":"100","author":"C Cunningham-Rundles","year":"2001","unstructured":"Cunningham-Rundles C, Bodian C et al (2001) Long-term low-dose IL-2 enhances immune function in common variable immunodeficiency. Clin Immunol 100(2):181\u2013190","journal-title":"Clin Immunol"},{"issue":"2","key":"8131_CR76","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2249.1997.tb08313.x","volume":"110","author":"JA Rump","year":"1997","unstructured":"Rump JA, Jahreis A et al (1997) A double-blind, placebo-controlled, crossover therapy study with natural human IL-2 (nhuIL-2) in combination with regular intravenous gammaglobulin (IVIG) infusions in 10 patients with common variable immunodeficiency (CVID). Clin Exp Immunol 110(2):167\u2013173","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"8131_CR77","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/0090-1229(92)90058-V","volume":"64","author":"C Cunningham-Rundles","year":"1992","unstructured":"Cunningham-Rundles C, Mayer L et al (1992) Restoration of immunoglobulin secretion in vitro in common variable immunodeficiency by in vivo treatment with polyethylene glycol-conjugated human recombinant interleukin-2. Clin Immunol Immunopathol 64(1):46\u201356","journal-title":"Clin Immunol Immunopathol"},{"issue":"2\u20133","key":"8131_CR78","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S1567-5769(01)00143-6","volume":"2","author":"RM Ten","year":"2002","unstructured":"Ten RM, Anderson PM et al (2002) Interleukin-2 liposomes for primary immune deficiency using the aerosol route. Int Immunopharmacol 2(2\u20133):333\u2013344","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"8131_CR79","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.4049\/jimmunol.130.6.2644","volume":"130","author":"N Flomenberg","year":"1983","unstructured":"Flomenberg N, Welte K et al (1983) Immunologic effects of interleukin 2 in primary immunodeficiency diseases. J Immunol 130(6):2644\u20132650","journal-title":"J Immunol"},{"issue":"3","key":"8131_CR80","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/jac\/dkn238","volume":"62","author":"C Herzmann","year":"2008","unstructured":"Herzmann C, Cuthbertson Z et al (2008) Long-term clinical and surrogate marker effects of subcutaneous intermittent interleukin-2 without antiretroviral therapy in HIV-infected patients. J Antimicrob Chemother 62(3):583\u2013586","journal-title":"J Antimicrob Chemother"},{"issue":"5534","key":"8131_CR81","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/258427a0","volume":"258","author":"AM Taylor","year":"1975","unstructured":"Taylor AM, Harnden DG et al (1975) Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity. Nature 258(5534):427\u2013429","journal-title":"Nature"},{"issue":"7","key":"8131_CR82","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1007\/BF00441517","volume":"148","author":"S Doi","year":"1989","unstructured":"Doi S, Saiki O et al (1989) Administration of recombinant IL-2 augments the level of serum IgM in an IL-2 deficient patient. Eur J Pediatr 148(7):630\u2013633","journal-title":"Eur J Pediatr"},{"issue":"2","key":"8131_CR83","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.iac.2008.01.003","volume":"28","author":"KE Sullivan","year":"2008","unstructured":"Sullivan KE (2008) Chromosome 22q11.2 deletion syndrome: DiGeorge syndrome\/velocardiofacial Syndrome. Immunol Allergy Clin North Am 28(2):353\u2013366","journal-title":"Immunol Allergy Clin North Am"},{"issue":"1","key":"8131_CR84","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0022-3476(98)70478-0","volume":"132","author":"ML Markert","year":"1998","unstructured":"Markert ML, Hummell DS et al (1998) Complete DiGeorge syndrome: persistence of profound immunodeficiency. J Pediatr 132(1):15\u201321","journal-title":"J Pediatr"},{"issue":"2","key":"8131_CR85","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1046\/j.1365-2249.1999.00886.x","volume":"116","author":"C Cunningham-Rundles","year":"1999","unstructured":"Cunningham-Rundles C, Murray HW et al (1999) Treatment of idiopathic CD4 T lymphocytopenia with IL-2. Clin Exp Immunol 116(2):322\u2013325","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"8131_CR86","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2500\/aap.2008.29.3143","volume":"29","author":"Y Yilmaz-Demirdag","year":"2008","unstructured":"Yilmaz-Demirdag Y, Wilson B et al (2008) Interleukin-2 treatment for persistent cryptococcal meningitis in a child with idiopathic CD4(+) T lymphocytopenia. Allergy Asthma Proc 29(4):421\u2013424","journal-title":"Allergy Asthma Proc"},{"issue":"4","key":"8131_CR87","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1001\/archderm.133.4.491","volume":"133","author":"AA Gaspari","year":"1997","unstructured":"Gaspari AA, Zalka AD et al (1997) Successful treatment of a generalized human papillomavirus infection with granulocyte-macrophage colony-stimulating factor and interferon gamma immunotherapy in a patient with a primary immunodeficiency and cyclic neutropenia. Arch Dermatol 133(4):491\u2013496","journal-title":"Arch Dermatol"},{"issue":"5","key":"8131_CR88","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S1081-1206(10)60764-8","volume":"98","author":"S Narula","year":"2007","unstructured":"Narula S, LaRosa DF et al (2007) Progressive multifocal leukoencephalopathy in a patient with common variable immunodeficiency and abnormal CD8+ T-cell subset distribution. Ann Allergy Asthma Immunol 98(5):483\u2013489","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-009-8131-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-009-8131-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-009-8131-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-009-8131-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T04:23:07Z","timestamp":1684988587000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-009-8131-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,16]]},"references-count":88,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["8131"],"URL":"https:\/\/doi.org\/10.1007\/s12016-009-8131-4","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,16]]},"assertion":[{"value":"16 May 2009","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}